Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 51% ± 15% | |
lung | 18 studies | 61% ± 16% | |
intestine | 13 studies | 44% ± 20% | |
brain | 13 studies | 32% ± 15% | |
eye | 10 studies | 46% ± 21% | |
kidney | 9 studies | 59% ± 18% | |
liver | 7 studies | 42% ± 18% | |
bone marrow | 6 studies | 34% ± 18% | |
lymph node | 6 studies | 59% ± 21% | |
pancreas | 4 studies | 57% ± 28% | |
placenta | 4 studies | 68% ± 26% | |
uterus | 4 studies | 68% ± 15% | |
skin | 4 studies | 60% ± 27% | |
adipose | 4 studies | 28% ± 13% | |
prostate | 4 studies | 55% ± 16% | |
breast | 4 studies | 70% ± 9% | |
adrenal gland | 3 studies | 46% ± 6% | |
esophagus | 3 studies | 50% ± 23% | |
thymus | 3 studies | 56% ± 28% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 10844.27 | 226 / 226 | 100% | 524.69 | 406 / 406 |
ovary | 100% | 7659.76 | 180 / 180 | 100% | 443.51 | 430 / 430 |
thymus | 100% | 9780.87 | 653 / 653 | 100% | 582.41 | 605 / 605 |
brain | 100% | 11119.80 | 2638 / 2642 | 100% | 374.97 | 705 / 705 |
skin | 100% | 9195.67 | 1809 / 1809 | 100% | 357.35 | 471 / 472 |
kidney | 100% | 14418.21 | 89 / 89 | 100% | 485.62 | 899 / 901 |
adrenal gland | 100% | 15822.48 | 258 / 258 | 100% | 451.49 | 229 / 230 |
prostate | 100% | 10433.46 | 245 / 245 | 99% | 424.69 | 499 / 502 |
lung | 99% | 9894.20 | 575 / 578 | 99% | 363.52 | 1149 / 1155 |
intestine | 100% | 6996.38 | 966 / 966 | 99% | 293.22 | 521 / 527 |
stomach | 99% | 5448.30 | 357 / 359 | 99% | 294.62 | 284 / 286 |
esophagus | 100% | 6957.08 | 1442 / 1445 | 99% | 257.68 | 181 / 183 |
breast | 100% | 22566.92 | 459 / 459 | 99% | 439.33 | 1103 / 1118 |
uterus | 99% | 6436.02 | 169 / 170 | 99% | 353.72 | 455 / 459 |
bladder | 100% | 9842.90 | 21 / 21 | 98% | 348.02 | 496 / 504 |
pancreas | 63% | 1913.58 | 205 / 328 | 99% | 325.85 | 177 / 178 |
adipose | 100% | 26078.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 339.77 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 484.59 | 29 / 29 |
spleen | 100% | 6546.51 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 364.91 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 410.15 | 1 / 1 |
muscle | 100% | 12200.11 | 801 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 11160.17 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 8496.26 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 6152.15 | 889 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0032355 | Biological process | response to estradiol |
GO_0007283 | Biological process | spermatogenesis |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0019372 | Biological process | lipoxygenase pathway |
GO_0110076 | Biological process | negative regulation of ferroptosis |
GO_0051258 | Biological process | protein polymerization |
GO_0042759 | Biological process | long-chain fatty acid biosynthetic process |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0019369 | Biological process | arachidonic acid metabolic process |
GO_0006979 | Biological process | response to oxidative stress |
GO_0005739 | Cellular component | mitochondrion |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0008430 | Molecular function | selenium binding |
GO_0047066 | Molecular function | phospholipid-hydroperoxide glutathione peroxidase activity |
GO_0004602 | Molecular function | glutathione peroxidase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GPX4 |
Protein name | phospholipid-hydroperoxide glutathione peroxidase (EC 1.11.1.12) (Glutathione peroxidase 4) Glutathione peroxidase Phospholipid hydroperoxide glutathione peroxidase GPX4 (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4) (EC 1.11.1.9) |
Synonyms | |
Description | FUNCTION: Essential antioxidant peroxidase that directly reduces phospholipid hydroperoxide even if they are incorporated in membranes and lipoproteins (By similarity). Can also reduce cholesterol hydroperoxide and thymine hydroperoxide (By similarity). Plays a key role in protecting cells from oxidative damage by preventing membrane lipid peroxidation (By similarity). Required to prevent cells from ferroptosis, a non-apoptotic cell death resulting from an iron-dependent accumulation of lipid reactive oxygen species . The presence of selenocysteine (Sec) versus Cys at the active site is essential for life: it provides resistance to overoxidation and prevents cells against ferroptosis (By similarity). The presence of Sec at the active site is also essential for the survival of a specific type of parvalbumin-positive interneurons, thereby preventing against fatal epileptic seizures (By similarity). May be required to protect cells from the toxicity of ingested lipid hydroperoxides (By similarity). Required for normal sperm development and male fertility (By similarity). Essential for maturation and survival of photoreceptor cells (By similarity). Plays a role in a primary T-cell response to viral and parasitic infection by protecting T-cells from ferroptosis and by supporting T-cell expansion (By similarity). Plays a role of glutathione peroxidase in platelets in the arachidonic acid metabolism . Reduces hydroperoxy ester lipids formed by a 15-lipoxygenase that may play a role as down-regulator of the cellular 15-lipoxygenase pathway (By similarity). Can reduce fatty acid-derived hydroperoxides . Can also reduce small soluble hydroperoxides such as H2O2, cumene hydroperoxide and tert-butyl hydroperoxide . . |
Accessions | A0A9L9PXS3 Q6PI42 ENST00000706713.1 ENST00000587648.5 ENST00000585362.7 ENST00000611653.4 [P36969-2] ENST00000593032.6 ENST00000589115.6 A0A0A0MTT1 K7ENB4 Q6PJX4 K7EJ20 ENST00000614791.1 ENST00000585480.1 K7EKX7 ENST00000706715.1 ENST00000588919.5 ENST00000354171.13 [P36969-1] K7ERP4 R4GNE4 A0A087X247 P36969 ENST00000706714.1 |